Requirement of a critical period of transcription for induction of a late phase of LTP

Science. 1994 Aug 19;265(5175):1104-7. doi: 10.1126/science.8066450.

Abstract

Repeated high-frequency trains of stimuli induce long-term potentiation (LTP) in the CA1 region that persists for up to 8 hours in hippocampal slices and for days in intact animals. This long time course has made LTP an attractive model for certain forms of long-term memory in the mammalian brain. A hallmark of long-term memory in the intact animal is a requirement for transcription, and thus whether the late phase of LTP (L-LTP) requires transcription was investigated here. With the use of different inhibitors, it was found in rat hippocampal slices that the induction of L-LTP [produced either by tetanic stimulation or by application of the cyclic adenosine monophosphate (cAMP) analog Sp-cAMPS (Sp-cyclic adenosine 3',5'-monophosphorothioate)] was selectively prevented when transcription was blocked immediately after tetanization or during application of cAMP. As with behavioral memory, this requirement for transcription had a critical time window. Thus, the late phase of LTP in the CA1 region requires transcription during a critical period, perhaps because cAMP-inducible genes must be expressed during this period.

Publication types

  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Animals
  • Cyclic AMP / analogs & derivatives
  • Cyclic AMP / metabolism
  • Cyclic AMP / pharmacology
  • Dactinomycin / pharmacology
  • Dichlororibofuranosylbenzimidazole / pharmacology
  • Electric Stimulation
  • Evoked Potentials / drug effects
  • Hippocampus / drug effects
  • Hippocampus / metabolism*
  • In Vitro Techniques
  • Long-Term Potentiation* / drug effects
  • Male
  • Pyramidal Cells / metabolism
  • Rats
  • Rats, Sprague-Dawley
  • Synaptic Transmission / drug effects
  • Thionucleotides / pharmacology
  • Transcription, Genetic* / drug effects

Substances

  • Thionucleotides
  • Dactinomycin
  • adenosine-3',5'-cyclic phosphorothioate
  • Dichlororibofuranosylbenzimidazole
  • Cyclic AMP